Cardarine (GW-501516) Ultima Pharmaceuticals
€108.00
Overview of Cardarine (GW-501516) Ultima Pharmaceuticals, history and composition
Cardarine, also known as GW-501516, is a performance-enhancing compound developed in the 1990s for the treatment of metabolic and cardiovascular diseases. Ultima Pharmaceuticals has gained attention for its formulation of this compound, targeted at athletes and fitness enthusiasts looking to boost endurance and improve overall athletic performance. Cardarine operates by activating the peroxisome proliferator-activated receptor delta (PPARδ), a key regulator of energy metabolism. Its unique composition influences how the body processes fatty acids and glucose, promoting a state conducive to fat loss and enhanced physical performance.
Physiological impact, what happens in the body
When Cardarine enters the body, it binds to PPARδ receptors, leading to a series of metabolic changes. Users often experience increased fatty acid oxidation, which helps in utilizing stored fat as a primary energy source. This shift reduces reliance on carbohydrates during exercise, allowing for prolonged physical activity without depleting glycogen stores. Furthermore, the compound enhances the body’s ability to combat fatigue by improving mitochondrial function and increasing exercise capacity. As a result, athletes may notice faster recovery times and improved endurance during high-intensity workouts.
How to acquire Cardarine (GW-501516) Ultima Pharmaceuticals, purchasing instructions
To acquire Cardarine (GW-501516) from Ultima Pharmaceuticals, it’s essential to source it from reputable suppliers. Potential users should opt for online pharmacies with verified credentials and positive customer feedback. Before purchase, verify that the product complies with regulations to ensure safety and efficacy. Typically, Cardarine is available in various forms, including capsules and powders. Always follow the manufacturer’s instructions for dosage and usage. Due diligence is crucial; consult with healthcare professionals prior to starting any new supplement regimen.
Contraindications, who should avoid it
While Cardarine can be beneficial for many, certain individuals should avoid using this compound. Pregnant or nursing women should refrain from usage due to potential unknown risks. People with liver problems or any pre-existing medical conditions should also exercise caution, as the impact of Cardarine on those conditions is not fully established. Additionally, those taking medications that affect liver enzymes or metabolism should consult a healthcare provider before considering Cardarine. It is paramount to understand personal health circumstances before introducing any new substance into one’s routine.
Key effects, main reasons for use
Cardarine’s popularity in the fitness community is attributed to several key effects that enhance athletic performance.
- Improves endurance by increasing the body’s ability to utilize fat as fuel.
- Reduces fatigue during prolonged exercise, allowing for longer training sessions.
- Aids in faster recovery due to enhanced cellular repair processes.
- Supports fat loss while preserving lean muscle mass.
- Enhances cardiovascular health by positively influencing lipid profiles.
These effects make Cardarine a highly sought-after compound for athletes looking to maximize their performance and achieve their goals.
| Active substance | Cardarine |
|---|---|
| Active Half-Life | 20-24 hours |
| Classification | PPAR-delta agonist |
| Dosage | 20 mg/day |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Detection in blood and urine tests |
| Also known as | GW-501516, Cardarine |
| WAREHOUSE | International Warehouse 3 |
| Blood pressure | No significant impact |
| Trade name | Not available as a legally approved drug |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Chemical name | {4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid |
| Formula | C21H18F3NO3S2 |
| Substance class | PPARОґ receptor agonist |
| Main action | Enhances fatty acid metabolism |
| Half-life | 16-24 hours |
| Dosage (medical) | Not medically approved for therapeutic use |
| Dosage (sports) | 10-20 mg per day |
| Effects | Increased endurance, fat loss, improved lipid profile |
| Side effects | Potential carcinogenic effects, liver toxicity, possible development of other cancers |
| Use in sports | Banned by major sports organizations |
| Manufacturer | Ultima Pharmaceuticals |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.